Clinical Trial Update: Determining Whether Durvalumab in Combination With Radiation Therapy Can Prevent the Progression of Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating whether adding durvalumab to radiation therapy can prevent progression of non-small cell lung cancer; the study is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Durvalumab (Imfinzi) (durvalumab)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Non Small Cell Lung Cancer, Lung Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING